---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-018857"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2022-09-26T23:59:59+00:00"
generated_at: "2026-06-23T07:27:41.596398+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Corbus appoints Anne Altmeyer, Ph.D. to Board of Directors

## Summary
- Dr. Altmeyer appointed to the Board effective September 20, 2022, until next annual meeting.
- She receives initial option to purchase 159,200 shares of common stock and $40,000 annual cash retainer.
- Altmeyer is President & CEO of TigaTx, former CBO at Sigilon Therapeutics and Adicet Bio, and held roles at Novartis and Baxalta.
- Appointment brings oncology R&D and corporate development expertise to Corbus pipeline expansion.
- Standard indemnification agreement executed; no reportable transactions under Item 404(a).

## SEC filing metadata
- accession: 0000950170-22-018857
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2022-09-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017022018857/0000950170-22-018857-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017022018857/crbp-20220920.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-018857
- JSON: https://secwatch.observer/filing/0000950170-22-018857.json
- Plain text: https://secwatch.observer/filing/0000950170-22-018857.txt

## Key facts
- Executive change
  Anne Altmeyer was appointed as Director at Corbus Pharmaceuticals Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Anne Altmeyer, Ph.D., MBA, MPH, age 58, to serve as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595097/000095017022018857/0000950170-22-018857-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.